NPPA Caps Trade Margins on Anti-Cancer Drugs
The National Pharmaceutical Pricing Authority (NPPA) has issued a Trade Margin Rationalisation (TMR) order capping margins on anti-cancer drugs, aiming to improve affordability. The move targets distribution inefficiencies but raises concerns about long-term sustainability and enforcement gaps.

